Literature DB >> 15556050

Elevated circulating levels of thioredoxin and stress in chronic heart failure.

Andreas Jekell1, Akter Hossain, Urban Alehagen, Ulf Dahlström, Anders Rosén.   

Abstract

BACKGROUND: Chronic heart failure (CHF) is a complex syndrome, in which reactive oxygen species and inflammatory cytokines are important stressors that contribute to the pathogenesis. AIM: We have studied physiological stress response parameters in CHF, in particular the redox-active regulator thioredoxin.
SUBJECTS: A case-control study was conducted including a consecutive sample of CHF patients (n=27) of NYHA class II and III; comparison control subjects (n=29) were recruited from an association for retired people.
METHOD: Baseline levels of Trx, lipid peroxides (oxidative stress), TNF and IL-6 cytokines, platelet-activation marker P-selectin, cortisol (as peripheral effector of HPA axis), and the potent antioxidant selenoprotein Trx-reductase were assessed.
RESULTS: Mean (+/-S.E.M.) plasma levels of Trx were significantly higher in patients with CHF (32+/-3 ng/ml), than in the healthy subjects (12+/-3 ng/ml, P<0.0001). Trx levels increased in proportion to severity of disease (NYHA class III>NYHA class II) and degree of stress. Trx elevation correlated well with increased oxidative stress (lipid peroxides, P<0.0001), circulatory P-selectin (P<0.0001), morning level of free salivary cortisol (P=0.0002), and serum creatinine (P=0.0417), but not with pro-inflammatory cytokines TNF and IL-6.
CONCLUSION: Trx was strikingly elevated in heart failure cases compared with controls, signifying an adaptive stress response that is higher the more severe the disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15556050     DOI: 10.1016/j.ejheart.2004.03.003

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  27 in total

1.  Selenium: its role as antioxidant in human health.

Authors:  Ujang Tinggi
Journal:  Environ Health Prev Med       Date:  2008-02-28       Impact factor: 3.674

2.  Angiotensin II and oxidative stress in the failing heart.

Authors:  Daniela Zablocki; Junichi Sadoshima
Journal:  Antioxid Redox Signal       Date:  2012-05-03       Impact factor: 8.401

3.  Improved Health-Related Quality of Life, and More Days out of Hospital with Supplementation with Selenium and Coenzyme Q10 Combined. Results from a Double Blind, Placebo-Controlled Prospective Study.

Authors:  P Johansson; Ö Dahlström; U Dahlström; U Alehagen
Journal:  J Nutr Health Aging       Date:  2015-11       Impact factor: 4.075

4.  Myotrophin/V-1 does not act as an extracellular signal to induce myocyte hypertrophy.

Authors:  Pascal Knuefermann; Shu-Ping Shi; Peter Chen; Yashushi Sakata; Georg Baumgarten; Natarajan Sivasubramanian
Journal:  Tex Heart Inst J       Date:  2006

Review 5.  Thioredoxin in the cardiovascular system.

Authors:  Cameron J World; Hideyuki Yamawaki; Bradford C Berk
Journal:  J Mol Med (Berl)       Date:  2006-10-05       Impact factor: 4.599

6.  A phase I trial of PX-12, a small-molecule inhibitor of thioredoxin-1, administered as a 72-hour infusion every 21 days in patients with advanced cancers refractory to standard therapy.

Authors:  Ramesh K Ramanathan; Joe J Stephenson; Glen J Weiss; Linda A Pestano; Ann Lowe; Alton Hiscox; Rafael A Leos; Julie C Martin; Lynn Kirkpatrick; Donald A Richards
Journal:  Invest New Drugs       Date:  2011-08-24       Impact factor: 3.850

Review 7.  Oxidative stress in heart failure: what are we missing?

Authors:  Douglas B Sawyer
Journal:  Am J Med Sci       Date:  2011-08       Impact factor: 2.378

8.  Thioredoxin and thioredoxin reductase control tissue factor activity by thiol redox-dependent mechanism.

Authors:  Pei Wang; Yunfei Wu; Xiaoming Li; Xiaofeng Ma; Liangwei Zhong
Journal:  J Biol Chem       Date:  2012-12-07       Impact factor: 5.157

9.  Redox responses in patients with sepsis: high correlation of thioredoxin-1 and macrophage migration inhibitory factor plasma levels.

Authors:  Thorsten Brenner; Claudia Rosenhagen; Jochen Steppan; Christoph Lichtenstern; Jürgen Weitz; Thomas Bruckner; Eike O Martin; Ursula Hoffmann; Markus A Weigand; Stefan Hofer
Journal:  Mediators Inflamm       Date:  2010-08-05       Impact factor: 4.711

Review 10.  Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling.

Authors:  Eva-Maria Hanschmann; José Rodrigo Godoy; Carsten Berndt; Christoph Hudemann; Christopher Horst Lillig
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.